AFM
ORTX

Anson Funds Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Anson Funds Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,827
Closed -$460K – 450
2021
Q4 		$460K Buy
+34,827
New +$576K 0.05% 254

Other funds holding ORTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Anson Funds Management's ORTX Position: Q1 2022 in Review

Anson Funds Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2022, closing a stake of 34,827 shares — an estimated $460K sold.

Anson Funds Management first reported a position in ORTX in Q4 2021 and held it in 1 quarter. The position peaked at $460K in Q4 2021. 61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

  • Anson Funds Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Anson Funds Management sold 34,827 Orchard Therapeutics plc American Depositary Shares shares in Q1 2022, an estimated $460K.
  • Anson Funds Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Anson Funds Management's Orchard Therapeutics plc American Depositary Shares position peaked at $460K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.